NATURE MEDICINE by admin | Jun 6, 2024 | in-the-news | 0 comments Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial